Monocytes in Subjects With Type 1 Diabetes and Chronic Kidney Disease

Recruiting now

Conditions studied: Chronic Kidney Disease(CKD), Type 1 Diabetes (T1D)

In brief

This is a cross-sectional study in patients with Type 1 diabetes (TID) and chronic kidney disease (CKD) to test if time in range (TIR) affects the degree of hyperglycemia required for monocyte activation, podocyte injury, and assess if monocyte activation is attenuated by glucagon-like peptide (GLP-1) agonist treatment ex vivo.

Key facts

Study ID
NCT06694558
Run by
The Cleveland Clinic
People needed
60
Starts
2025-03-01
Expected to finish
2027-07-01
Last updated by the study team
2026-07-08

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.